FDA authorizes Roche drug for severely ill COVID-19 patients

FDA authorizes Roche drug for severely ill COVID-19 patients



The Food and Drug Administration granted emergency approval to Roche’s Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving oxygen and steroid medications.